We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The latest decision ends the drugmakers’ Truvada patent challenges before the board. The matter is now in the hands of the U.S. District Court for the District of Delaware, where HHS has sued the drugmaker for patent infringement. Read More